Adverse effects of immunotherapeutics involving the immune system

Toxicology ◽  
2002 ◽  
Vol 174 (1) ◽  
pp. 3-11 ◽  
Author(s):  
T. Vial ◽  
G. Choquet-Kastylevsky ◽  
J. Descotes
2021 ◽  
Vol 11 ◽  
Author(s):  
Andi Zhang ◽  
Tianyuan Zou ◽  
Dongye Guo ◽  
Quan Wang ◽  
Yilin Shen ◽  
...  

As a stressor widely existing in daily life, noise can cause great alterations to the immune system and result in many physical and mental disorders, including noise-induced deafness, sleep disorders, cardiovascular diseases, endocrine diseases and other problems. The immune system plays a major role in maintaining homeostasis by recognizing and removing harmful substances in the body. Many studies have shown that noise may play vital roles in the occurrence and development of some immune diseases. In humans, both innate immunity and specific immunity can be influenced by noise, and different exposure durations and intensities of noise may exert various effects on the immune system. Short-term or low-intensity noise can enhance immune function, while long-term or high-intensity noise suppresses it. Noise can lead to the occurrence of noise-induced hearing loss (NIHL) through the production of autoantibodies such as anti-Hsp70 and anti-Hsp60 and exert adverse effects related to other immune-related diseases such as some autoimmune diseases and non-Hodgkin lymphoma. The neuroendocrine system, mainly including the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic-adrenal-medullary (SAM) system, is involved in the mechanisms of immune-related diseases induced by noise and gut microbiota dysfunction. In addition, noise exposure during pregnancy may be harmful to the immune system of the fetus. On the other hand, some studies have shown that music can improve immune function and alleviate the adverse effects caused by noise.


2022 ◽  
pp. 1184-1202
Author(s):  
Anamika Basu ◽  
Anasua Sarkar ◽  
Piyali Basak

An allergy is an overreaction of the immune system to a substance called an antigen, e.g., pollen from grasses, dust mites, etc. The drugs used for allergy in allopathy have undesirable side effects. The use of medicinal plants becomes popular due to the adverse effects of allopathic drugs. Nutraceuticals are food playing a significant role in maintaining normal physiological function. Mast cells are immunologically important cells found in almost all parts of our body, and contain histamines, leukotrienes within their granular sacs, along with those of basophils, are responsible for the symptoms of allergy. According to sources mast cell stabilizers can be classified into three categories, e.g., synthetic, semi synthetic and natural. Mast cell stabilising agents from natural resources can be obtained from different group of compounds, e.g., flavonoids, coumarins, phenols, terpenoids, alkaloids. In this book chapter, the active constituents present in them and their mode of action are highlighted using techniques of computational biology, e.g., molecular docking, etc.


2020 ◽  
Vol 9 ◽  
Author(s):  
Fabiola Gianella ◽  
Connie CW Hsia ◽  
Khashayar Sakhaee

After the initial description of extrarenal synthesis of 1,25-dihydroxyvitamin D (1,25-(OH)2D) three decades ago, extensive progress has been made in unraveling the immunomodulatory roles of vitamin D in the pathogenesis of granulomatous disorders, including sarcoidosis. It has been shown that 1,25-(OH)2D has dual effects on the immune system, including upregulating innate immunity as well as downregulating the autoimmune response. The latter mechanism plays an important role in the pathogenesis and treatment of sarcoidosis. Vitamin D supplementation in patients with sarcoidosis has been hampered owing to concerns about the development of hypercalcemia and hypercalciuria given that extrarenal 1-α hydroxylase is substrate dependent. Recently, a few studies have cast doubt over the mechanisms underlying the development of hypercalcemia in this population. These studies demonstrated an inverse relationship between the level of vitamin D and severity of sarcoidosis. Consequently, clinical interest has been piqued in the use of vitamin D to attenuate the autoimmune response in this disorder. However, the development of hypercalcemia and the attendant detrimental effects are real possibilities. Although the average serum calcium concentration did not change following vitamin D supplementation, in two recent studies, hypercalciuria occurred in one out of 13 and two out of 16 patients. This review is a concise summary of the literature, outlining past work and newer developments in the use of vitamin D in sarcoidosis. We feel that larger-scale placebo-controlled randomized studies are needed in this population. Since the current first-line treatment of sarcoidosis is glucocorticoids, which confer many systemic adverse effects, and steroid-sparing immunosuppressant treatment options carry additional risks of adverse effects, adjunct management with vitamin D in combination with potent anti-osteoporotic medications could minimize the risk of glucocorticoid-induced osteoporosis and modulate the immune system to attenuate disease activity in sarcoidosis.


2017 ◽  
Vol 58 (4) ◽  
pp. 321 ◽  
Author(s):  
I. DOSIS (Ι. ΔΟΣΗΣ) ◽  
A. KAMARIANOS (Α. ΚΑΜΑΡΙΑΝΟΣ)

Endocrine disrupting compounds (EDCs) encompass a variety of chemical classes, including several different categories of substances. Some are natural, such as plant oestrogens and mycoestrogens, while most are chemically composed. Residues are found in water, in sewage sludge, in the atmosphere and in foodstuff of vegitative or animal origin. The most common compounds include organochlorine pesticides, alkyl phenols, pthalates, polychlorinated biphenyls (PCBs), dioxins and polybrominated diphenyl ethers (PBDEs). Their properties render some as ubiquitous and persistent in the environment, they can be transported long distances and have been found in virtually all regions of the world. Their sources can vary from direct, such as effluents from wastewater, sewage, industrial sludge processes or agricultural effluents, to indirect, such as filtering agricultural soils, transportation through rain or air from civil and industrial centers to rivers and the surrounding environment. Others are rapidly degraded in the environment or human body or may be present for only short periods of time, but at critical periods of development. Although in low concentrations, the continuous exposure of animals of many species, including humans, induces adverse effects, such as disruption of reproductive function and of the immune system, as well as carcinogenic effects. The effects are obvious in wildlife, especially fish, and laboratory experiments. Sex change (feminizing) in fish has been observed, sexual differentiation in rats, egg shelling thinning, thyroid function disruption and mental and physical function disruption in wildlife. Most important and common is the disruption in the reproductive and the immune system of animals. As far as humans are concerned, reduction in sperm count and sperm quality has been heavily linked with EDC exposure, and furthermore, suspicions arise linking several cancer incident increments, such as testicular cancer, to EDC exposure. Still, although it is clear that many environmental chemicals can interfere with normal hormonal processes, there is weak evidence that human health can be adversely and directly affected by exposure to endocrine active chemicals. However, there is sufficient evidence to conclude that adverse endocrine mediated effects have occurred in wildlife species and laboratory studies exist to support these conclusions. The routes of exposure are numerous. Food is a common route of exposure, especially in younger animals that consume food containing higher fat percentages (e.g. milk). Soil is another route of exposure. Thus grazing animals tend to have a higher risk factor, due to surface soil pollution with EDCs. A vegetative nutrition with EDC residues is another high risk factor for these animals. On the other hand, animals bred with forage tend to be at lower risk factor, given that food is tested for low levels of EDCs. Water intake is not considered a significant route of exposure. EDCs possess the ability to act as either hormone agonists or antagonists or disrupt hormone synthesis, storage or metabolism. Due to their persistence in the environment, they are concentrated in fat tissue and are released when the fat is mobilized duringpregnancy or lactation, thus exposing embryos and neonates, which are very susceptible at this stage of development, to high concentrations of EDCs. The concerns that arise regarding the exposure to these EDCs are due primarily to:- these adverse effects observed in certain wildlife, fish and ecosystems- the increased incidences of certain endocrine-related human diseases and- endocrine disruption resulting from exposure to certain environmental chemicals observed in laboratory experimental animals.


2020 ◽  
Vol 114 (7) ◽  
pp. 541-544
Author(s):  
Sajad Rashidi ◽  
Kurosh Kalantar ◽  
Paul Nguewa ◽  
Gholamreza Hatam

Abstract Optimum levels of selenoproteins are essential for starting and managing the host immune responses against pathogens. According to the expression of selenoproteins in Leishmania parasites, and since high levels of selenoproteins lead to adverse effects on immune cells and their functions, Leishmania parasites might then express selenoproteins such as selenomethionine in their structure and/or secretions able to challenge the host immune system. Finally, this adaptation may lead to evasion of the parasite from the host immune system. The expression of selenoproteins in Leishmania parasites might then induce the development of infection. We therefore suggest these molecules as new therapeutic candidates for the treatment of leishmaniasis.


PLoS ONE ◽  
2014 ◽  
Vol 9 (2) ◽  
pp. e88181 ◽  
Author(s):  
Prakash Pragya ◽  
Arvind Kumar Shukla ◽  
Ramesh Chandra Murthy ◽  
Malik Zainul Abdin ◽  
Debapratim Kar Chowdhuri

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A136-A137
Author(s):  
Norma Vergne-Santiago ◽  
Ernesto Jos E Sola Sanchez ◽  
Michelle Marie Mangual Garcia

Abstract The superlative therapeutic response of cancer immunotherapy is activation of the immune system against cancer cells. Currently, one of the most considered immune system enhancer are the immunomodulatory antibodies well known as checkpoint inhibitor therapy. Among this type of treatment, programed cell death-1 receptor blocker, is one of the most sought-after therapies on demand now a day. Notwithstanding the important clinical benefits of this therapeutic modality, serial autoimmune adverse effects and variety of atypical presentations of life-threatening endocrinopathies are expected to occur. We present a case of a 78-year-old man with dyslipidemia and lung CA who was referred to our clinic after developing electrolyte disturbances with associated dizziness and fatigue one month after Pembrolizumab therapy initiation. Physical exam was unremarkable. Laboratory data was consistent with mild hyponatremia, hyperkalemia and adequate fasting blood sugar levels. Aldosterone levels were extremely low, ACTH levels were extremely high with inappropriate low total cortisol response and negative 21-Hydroxylase antibodies. Diagnosis of primary adrenal insufficiency was established and Fludrocortisone 0.05 mg PO daily therapy was started with further resolution of hyponatremia and initial symptoms. In addition, concurrent primary hyperthyroidism along with thyroid RAIU-Scan results were consistent with thyroiditis, but TSI and TPO’s antibody levels were unexpectedly negative. Eventually, a suspicious thyroid nodule was identified requiring biopsy. Initial FNA results showed a follicular lesion of undetermined significance followed by a benign finding when repeated after six months. During follow up, patient’s primary hyperthyroidism converted to severe primary hypothyroidism without any intervention for her prior hyperthyroidism. Patient’s TPO’s levels remain undetectable and his current status is post-thyroiditis with residual primary hypothyroidism. Primary adrenal insufficiency also persist and its antibodies have not yet been identified either. It is known that autoimmunity can predispose to the development of primary adrenal and thyroid disorders in patients undergoing PD-1 receptor blockers therapy against cancer. Both disorders are increasingly recognized and reported as one of the most common adverse effects presenting in patients treated with these agents. However, to our knowledge, cases of non-immune related adverse effects are barely documented. This case of uncommon endocrine manifestations related to checkpoint inhibitors therapy is meritorious of being reported since it should raise awareness in the medical community for prompt identification of signs and symptoms, as well as to offer adequate management, accurate treatment and provide a better standard of care.


Sign in / Sign up

Export Citation Format

Share Document